Clinical Trial Update: A Study to Test Different Doses of BI 1584862 in People With a Distinct Form of Age-related Macular Degeneration (AMD) Called Geographic Atrophy [Phase 2]

View source ↗

Summary

A Phase 2 study is evaluating different doses of BI 1584862 for geographic atrophy, a form of age-related macular degeneration; the trial is currently active bu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Geographic Atrophy

Drugs mentioned

• BI 1584862

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Geographic Atrophy | Phase 2 | Status: ACTIVE_NOT_RECRUITING